Are image‑guided epidural steroid injections appropriate for a patient with an annular tear of an intervertebral disc who has persistent radicular or axial back pain despite activity modification, NSAIDs, and physical therapy?

Epidural Steroid Injections for Annular Tears: Not Recommended

Do not offer image-guided epidural steroid injections for patients with annular tears who have persistent radicular or axial back pain despite conservative management. The most recent and highest quality evidence—the 2025 BMJ clinical practice guideline—issues strong recommendations AGAINST epidural steroid injections for both chronic axial and chronic radicular spine pain 1.

The Evidence Against Intervention

The 2025 BMJ guideline represents a rigorous, evidence-based analysis that explicitly addresses your clinical scenario. This guideline makes strong recommendations against the following for chronic spine pain (≥3 months):

For Chronic Axial Spine Pain:

• Epidural injection of local anesthetic, steroids, or their combination
• All joint-based interventions
• Intramuscular injections

For Chronic Radicular Spine Pain:

• Epidural injection of local anesthetic, steroids, or their combination
• Dorsal root ganglion radiofrequency procedures

The guideline defines "strong recommendation against" as meaning "all or nearly all well-informed people would likely not want such interventions" and states these "should therefore not be offered outside of a clinical trial" 1.

Understanding the Contradiction in Guidelines

You'll encounter conflicting guidance in practice. The 2021 ASIPP guidelines and 2022 ASPN guidelines recommend epidural injections for disc disease and axial discogenic pain 1. However, the 2025 BMJ guideline explicitly addresses this inconsistency, noting that a 2023 synthesis of 21 clinical practice guidelines found "no consistency in recommendations for or against any interventional procedure" 1.

The critical difference: Many pro-intervention guidelines are consensus-based rather than evidence-based, often authored by interventionalists with potential conflicts of interest. An analysis found positive results were three times more likely when reviews were authored by interventionalists versus non-interventionalists 1.

The 2020 NICE guideline aligns with the BMJ recommendation, stating: "Do not offer spinal injections for managing low back pain" 1.

Risk-Benefit Analysis

Risks to Consider:

• Small risk of moderate to serious harms: deep infection, temporary altered consciousness 1
• Very small risk of catastrophic harms: paralysis and death following epidural steroid injection 1
• The FDA issued a 2014 safety warning specifically about neurological complications from epidural corticosteroids 2
• Particulate steroids carry higher risk than non-particulate formulations, particularly with transforaminal approaches 2

Benefit Evidence:

The guideline panel determined there is very low certainty of evidence for benefit or low certainty of evidence for no benefit 1. Patients in the guideline's values assessment indicated they would be "disinclined to receive treatment with an interventional procedure" under these evidence conditions 1.

Clinical Algorithm for Your Patient

Step 1: Confirm Conservative Management Adequacy

• Has the patient completed at least 6 weeks of optimal conservative therapy?
• Conservative therapy includes: activity modification, NSAIDs, physical therapy, remaining active, and exercise programs 3

Step 2: Reassess for Red Flags

• Progressive neurological deficits
• Cauda equina symptoms
• Severe or progressive motor weakness
• These would warrant surgical evaluation, not injections

Step 3: Consider MRI if Not Already Done

• MRI is appropriate for surgical or intervention candidates after 6 weeks of failed conservative therapy 3
• However, note that annular tears and disc abnormalities are commonly seen in asymptomatic individuals 3
• The correlation between imaging findings and symptoms is low 1

Step 4: Management Recommendation

• Continue conservative management with emphasis on exercise and functional restoration
• Consider multidisciplinary pain management approaches (non-interventional)
• Avoid epidural steroid injections based on current best evidence
• If considering any intervention, it should only be within a clinical trial context 1

Important Caveats

When Guidelines Don't Apply:

These recommendations specifically apply to chronic spine pain (≥3 months duration) not associated with cancer or inflammatory arthropathy 1. They do not apply to acute spine pain management.

The Annular Tear Specificity:

While the guidelines address "axial discogenic pain" (which includes annular tears) with moderate to strong recommendations against intervention 1, some older guidelines like the 2021 ASIPP recommended injections for this indication. The 2025 BMJ guideline supersedes these based on more rigorous evidence evaluation.

Future Research Needs:

The guideline acknowledges uncertainty about whether treatment effects differ based on specific subtypes of chronic spine pain 1. However, until such evidence emerges, the precautionary principle applies: avoid interventions with potential serious harms when benefit is uncertain.

Cost and Access Considerations

Even if considering intervention, recognize that:

• Procedures require repeated visits every 2 weeks to 3 months 1
• Significant out-of-pocket expenses may apply
• Travel to specialized facilities is required
• The 2016 US healthcare spending on low back and neck pain reached $134.5 billion, with 9.2% being patient out-of-pocket costs 1

Bottom Line

The highest quality, most recent evidence strongly recommends against epidural steroid injections for your patient with an annular tear and persistent pain despite conservative management. Continue non-interventional approaches and consider referral to comprehensive pain management programs that emphasize functional restoration rather than procedural interventions 1.